These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10656451)

  • 1. Drug-induced apoptosis in lung cnacer cells is not mediated by the Fas/FasL (CD95/APO1) signaling pathway.
    Ferreira CG; Tolis C; Span SW; Peters GJ; van Lopik T; Kummer AJ; Pinedo HM; Giaccone G
    Clin Cancer Res; 2000 Jan; 6(1):203-12. PubMed ID: 10656451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
    Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
    Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
    Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH
    Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells.
    Dorothee G; Ameyar M; Bettaieb A; Vergnon I; Echchakir H; Bouziane M; Chouaib S; Mami-Chouaib F
    Int J Cancer; 2001 Mar; 91(6):772-7. PubMed ID: 11275978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
    Villunger A; Egle A; Kos M; Hartmann BL; Geley S; Kofler R; Greil R
    Cancer Res; 1997 Aug; 57(16):3331-4. PubMed ID: 9269989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
    J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction.
    Wesselborg S; Engels IH; Rossmann E; Los M; Schulze-Osthoff K
    Blood; 1999 May; 93(9):3053-63. PubMed ID: 10216102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
    Tolis C; Peters GJ; Ferreira CG; Pinedo HM; Giaccone G
    Eur J Cancer; 1999 May; 35(5):796-807. PubMed ID: 10505042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Fas/Fas ligand-mediated apoptosis by gossypol in an immortalized human alveolar lung cancer cell line.
    Chang JS; Hsu YL; Kuo PL; Chiang LC; Lin CC
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):716-22. PubMed ID: 15554914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.
    Ferreira CG; Span SW; Peters GJ; Kruyt FA; Giaccone G
    Cancer Res; 2000 Dec; 60(24):7133-41. PubMed ID: 11156422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
    Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT
    Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the Fas/Fas ligand system in p53-mediated granulosa cell apoptosis during follicular development and atresia.
    Kim JM; Yoon YD; Tsang BK
    Endocrinology; 1999 May; 140(5):2307-17. PubMed ID: 10218984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Fas and Fas ligand expression and function in lung cancer cell lines.
    Kawasaki M; Kuwano K; Nakanishi Y; Hagimoto N; Takayama K; Pei XH; Maeyama T; Yoshimi M; Hara N
    Eur J Cancer; 2000 Mar; 36(5):656-63. PubMed ID: 10738132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release.
    Raisova M; Bektas M; Wieder T; Daniel P; Eberle J; Orfanos CE; Geilen CC
    FEBS Lett; 2000 May; 473(1):27-32. PubMed ID: 10802053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-induced apoptosis of S-type neuroblastoma cells requires caspase-9 and is augmented by CD95/Fas stimulation.
    Bian X; Giordano TD; Lin HJ; Solomon G; Castle VP; Opipari AW
    J Biol Chem; 2004 Feb; 279(6):4663-9. PubMed ID: 14617634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.